parexel.com

Avaliação do site parexel.com

CRO & Biopharmaceutical Services | Parexel

 Gerado a 07 de Março de 2026 21:15 PM

Estatísticas desatualizadas? ATUALIZE !

O resultado é de 60/100

Conteúdo SEO

Título

CRO & Biopharmaceutical Services | Parexel

Cumprimento : 42

Perfeito, o Título contém entre 10 e 70 caracteres.

Descrição

For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.

Cumprimento : 129

Perfeito, a Descrição META contém entre 70 e 160 caracteres.

Palavras-chave

biopharmaceutical services

Perfeito, a página contém palavras-chave META.

Propriedades Og Meta

Esta página não tira vantagens das propriedades Og.

Cabeçalhos

H1 H2 H3 H4 H5 H6
1 2 51 8 32 0
  • [H1] Who we are,
  • [H2] While running a triathlon, Andrea stumbled and realized something was wrong.
  • [H2] Parexel is proudly among the world’s largest clinical research organizations
  • [H3] Solutions
  • [H3] Portfolio management and asset valuation
  • [H3] Early development and innovation
  • [H3] Integrated clinical development
  • [H3] Approval and access
  • [H3] Value substantiation lifecycle management
  • [H3] Operational excellence
  • [H3] Biotech
  • [H3] Therapeutic Expertise
  • [H3] General medicine
  • [H3] Infectious disease and vaccines
  • [H3] Immunology
  • [H3] Oncology
  • [H3] Neuroscience
  • [H3] Hematology
  • [H3] Insights
  • [H3] Participate
  • [H3] Patient volunteers
  • [H3] Sites
  • [H3] About
  • [H3] Leadership team
  • [H3] Compliance, tax & privacy
  • [H3] Solutions
  • [H3] Portfolio management and asset valuation
  • [H3] Early development and innovation
  • [H3] Integrated clinical development
  • [H3] Approval and access
  • [H3] Value substantiation lifecycle management
  • [H3] Operational excellence
  • [H3] Biotech
  • [H3] Therapeutic Expertise
  • [H3] General medicine
  • [H3] Infectious disease and vaccines
  • [H3] Immunology
  • [H3] Oncology
  • [H3] Neuroscience
  • [H3] Hematology
  • [H3] Insights
  • [H3] Participate
  • [H3] Patient volunteers
  • [H3] Sites
  • [H3] About
  • [H3] Leadership team
  • [H3] Compliance, tax & privacy
  • [H3] She thought it was just an injury. Her hamstrings were tight, and her body felt stiff and slow.
  • [H3] She had ALS, a condition affecting more than 200,000 people around the world.
  • [H3] Her life expectancy was shortened to just two to five years — but she was determined to make the most of it.
  • [H3] Andrea continued to join triathlons, even as she underwent treatment in a clinical trial, inspiring many and raising $1,000,000 for ALS research.
  • [H3] Today, alive beyond her original prognosis, she serves on our Patient Advisory Council, using her experiences to help improve our neuroscience trials.
  • [H3] Lives can change when you design neuroscience trials with speed and precision.
  • [H3] We focus on patients, because they inspire us to deliver better trials, faster than ever. So we can make a difference for more patients everywhere.
  • [H4]
  • [H4] Oncology
  • [H4] I&I
  • [H4] Cell & Gene Therapy
  • [H4] Endocrine & Metabolic
  • [H4] Resources
  • [H4] Regional Websites
  • [H4] Quick Links
  • [H5] WHAT WE DO
  • [H5] HOW WE DO IT
  • [H5] PODCAST
  • [H5] THERAPEUTIC EXPERTISE
  • [H5] CROSS-THERAPEUTIC EXPERTISE
  • [H5] RELATED INSIGHTS
  • [H5] NEW MEDICINES, NOVEL INSIGHTS
  • [H5] FEATURED INSIGHTS
  • [H5] RECENT INSIGHTS
  • [H5]
  • [H5] Biopharm workforce report
  • [H5] Powered by people
  • [H5] INTERESTED IN PARTICIPATING?
  • [H5] TRIAL SITES
  • [H5] HEAR FROM REAL PATIENTS
  • [H5] AWARD-WINNING-PARTNERS
  • [H5] WHAT WE DO
  • [H5] HOW WE DO IT
  • [H5] PODCAST
  • [H5] THERAPEUTIC EXPERTISE
  • [H5] CROSS-THERAPEUTIC EXPERTISE
  • [H5] RELATED INSIGHTS
  • [H5] NEW MEDICINES, NOVEL INSIGHTS
  • [H5] FEATURED INSIGHTS
  • [H5] RECENT INSIGHTS
  • [H5]
  • [H5] Biopharm workforce report
  • [H5] Powered by people
  • [H5] INTERESTED IN PARTICIPATING?
  • [H5] TRIAL SITES
  • [H5] HEAR FROM REAL PATIENTS
  • [H5] AWARD-WINNING-PARTNERS

Imagens

Encontrámos 23 imagens nesta página.

Bom, a maioria das imagens têm o atributo ALT definidos.

Rácio Texto/HTML

Rácio : 24%

Bom! O rácio de texto para código HTML desta página é maior que 15, mas menor que 25 porcento.

Flash

Perfeito, não foi encontrado conteúdo Flash nesta página.

Iframe

Oh, não, esta página tem Iframes na página, o que significa que o conteúdo destas não pode ser indexado.

Reescrita de URL

Perfeito. As ligações aparentam ser limpas!

Underscores (traços inferiores) nas URLs

Perfeito. Não foram encontrados 'underscores' (traços inferiores) nas suas URLs.

Ligações para a própria página

Encontrámos um total de 162 ligações incluindo 0 ligações a ficheiros

Âncoras Tipo Sumo
Solutions Internas Passa sumo
Portfolio management and asset valuation Internas Passa sumo
Early development and innovation Internas Passa sumo
Integrated clinical development Internas Passa sumo
Approval and access Internas Passa sumo
Value substantiation lifecycle management Internas Passa sumo
Delivery models Internas Passa sumo
Operational excellence Internas Passa sumo
Medical affairs Internas Passa sumo
Study start-up Internas Passa sumo
Overview Internas Passa sumo
Building patient insights into assets, profile and claims Internas Passa sumo
Portfolio optimization Internas Passa sumo
Asset valuation and indication prioritization Internas Passa sumo
Early evidence review Internas Passa sumo
Integrated development strategy and planning Internas Passa sumo
Phase I Clinical Trials Internas Passa sumo
Site Alliance Network and KOL Engagement Internas Passa sumo
Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) Internas Passa sumo
Regulatory Strategy Internas Passa sumo
Real World Evidence Internas Passa sumo
Market Access Consulting, Strategy, and Delivery Internas Passa sumo
Biomarker and Genomic Medicine Strategy Internas Passa sumo
Integrated evidence generation planning Internas Passa sumo
Medical Communications Internas Passa sumo
Phase IIB-IV Clinical Trials Internas Passa sumo
Real World Evidence Internas Passa sumo
Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) Internas Passa sumo
Protocol-Driven, Customized Site Solution Strategy Internas Passa sumo
Patient Inclusion Internas Passa sumo
Regulatory Strategy, Submissions, Compliance, and Outsourcing Internas Passa sumo
Market Access Strategy and Delivery Internas Passa sumo
Clinical Development Technology Optimization Internas Passa sumo
Clinical Trial Supply & Logistics Internas Passa sumo
Integrated evidence generation planning Internas Passa sumo
Medical Communications Internas Passa sumo
Drug Safety and Pharmacovigilance Internas Passa sumo
Global Regulatory Submissions and Outsourcing Internas Passa sumo
Real World Evidence Internas Passa sumo
Compliance and Risk Management Internas Passa sumo
Market Access Strategy and Delivery Internas Passa sumo
Integrated evidence generation planning Internas Passa sumo
Medical Communications Internas Passa sumo
Drug Safety and Pharmacovigilance Internas Passa sumo
Health economics modelling and simulation Internas Passa sumo
Real-World Evidence, Market Access Strategy and Planning Internas Passa sumo
Regulatory Compliance Internas Passa sumo
Lifecycle Optimization Internas Passa sumo
Integrated evidence generation planning Internas Passa sumo
Medical Communications Internas Passa sumo
Gain an advantage through FSP Internas Passa sumo
Leveraging AI in clinical development Internas Passa sumo
Medical affairs for clinical trials Internas Passa sumo
Biotech Internas Passa sumo
Listen Now Internas Passa sumo
Therapeutic Expertise Internas Passa sumo
Neuroscience Internas Passa sumo
General medicine Internas Passa sumo
Infectious disease and vaccines Internas Passa sumo
Immunology Internas Passa sumo
Oncology Internas Passa sumo
Hematology Internas Passa sumo
Cell and gene therapies Internas Passa sumo
Pediatrics Internas Passa sumo
Rare diseases Internas Passa sumo
Overview Internas Passa sumo
Cell and gene therapy Internas Passa sumo
Gastroenterology CRO Internas Passa sumo
Respiratory CRO Internas Passa sumo
Endocrine & Metabolic CRO Internas Passa sumo
Cardiovascular CRO Internas Passa sumo
Women's health CRO Internas Passa sumo
Critical Care Internas Passa sumo
Hepatitis B Internas Passa sumo
Novel treatments in infectious disease Internas Passa sumo
Ophthalmology CRO Internas Passa sumo
Dermatology CRO Internas Passa sumo
Allergy CRO Internas Passa sumo
Bladder cancer CRO Internas Passa sumo
Breast cancer CRO Internas Passa sumo
Gynecologic cancer CRO Internas Passa sumo
Head and neck cancer CRO Internas Passa sumo
Lung cancer CRO Internas Passa sumo
Phase I and rare tumors Internas Passa sumo
Prostate cancer CRO Internas Passa sumo
Neurology Internas Passa sumo
Psychiatry Internas Passa sumo
Pediatrics Internas Passa sumo
Rare Diseases Internas Passa sumo
Lymphoma CRO Internas Passa sumo
Acute myelogenous leukemia (AML) CRO Internas Passa sumo
Myelodysplastic syndrome (MDS) CRO Internas Passa sumo
Multiple Myeloma CRO Internas Passa sumo
Learn more Internas Passa sumo
Learn more Internas Passa sumo
Insights Internas Passa sumo
New frontiers in neuroscience Internas Passa sumo
Precision oncology Internas Passa sumo
Rare disease drug development Internas Passa sumo
Cell and gene therapy development Internas Passa sumo
Patient-guided drug development Internas Passa sumo
Clinical Trialblazers Podcast Internas Passa sumo
The Regulatory Navigator Internas Passa sumo
On The Pulse Internas Passa sumo
Learn more Internas Passa sumo
Learn more Internas Passa sumo
Participate Internas Passa sumo
Healthy volunteers Internas Passa sumo
Patient volunteers Internas Passa sumo
Patient advocacy groups Internas Passa sumo
Baltimore Externas Passa sumo
Los Angeles Externas Passa sumo
London Externas Passa sumo
Berlin Externas Passa sumo
Overview Internas Passa sumo
Advisory Council Internas Passa sumo
Patient stories Internas Passa sumo
Andrea & David's Story Internas Passa sumo
Stacy's Story Internas Passa sumo
Anisha's Story Internas Passa sumo
Rob's Story Internas Passa sumo
Learn more Internas Passa sumo
Sites Internas Passa sumo
Learn more Internas Passa sumo
About Internas Passa sumo
Leadership team Internas Passa sumo
Global reach Internas Passa sumo
Our inclusion strategy Internas Passa sumo
Our ESG strategy Internas Passa sumo
Compliance, tax & privacy Internas Passa sumo
Meet us at an event Internas Passa sumo
Overview Internas Passa sumo
Board of Directors Internas Passa sumo
Our ESG strategy Internas Passa sumo
Compliance & Ethics Internas Passa sumo
Tax Strategy Internas Passa sumo
Privacy Policy Internas Passa sumo
Cookies and other web tracking Internas Passa sumo
Supplier Data Privacy Requirements Internas Passa sumo
Terms of Use Internas Passa sumo
French Gender Pay Data Internas Passa sumo
UK Gender Pay Data Internas Passa sumo
UK Modern Slavery Act Statement Internas Passa sumo
Ireland Gender Pay Data Internas Passa sumo
Supplier Inclusion Policy Internas Passa sumo
Newsroom Internas Passa sumo
Academy Externas Passa sumo
Careers Internas Passa sumo
中国 (China) Internas Passa sumo
日本 (Japan) Internas Passa sumo
Contact Us Internas Passa sumo
Oncology Internas Passa sumo
Immunology Internas Passa sumo
Cell & Gene Therapy Internas Passa sumo
Endocrine & Metabolic Internas Passa sumo
See neuroscience capabilities Internas Passa sumo
Explore neuroscience careers Internas Passa sumo
biopharmaceutical leaders and sites Internas Passa sumo
Contact us Internas Passa sumo
My Communication Preferences Internas Passa sumo
Invoicing Internas Passa sumo
PO Terms and Conditions Internas Passa sumo

Palavras-chave SEO

Núvem de palavras-chave

patient clinical access more overview development medical trials cro strategy

Consistência das Palavras-chave

Palavra-chave Conteúdo Título Palavras-chave Descrição Cabeçalhos
clinical 55
cro 50
overview 44
development 36
strategy 30

Usabilidade

Url

Domínio : parexel.com

Cumprimento : 11

Favicon

Ótimo, o site tem um favicon.

Facilidade de Impressão

Não encontrámos CSS apropriado para impressão.

Língua

Otimo! A língua declarada deste site é en.

Dublin Core

Esta página não tira vantagens do Dublin Core.

Documento

Tipo de Documento

HTML 5

Codificação

Perfeito. O conjunto de caracteres UTF-8 está declarado.

Validação W3C

Erros : 0

Avisos : 0

Privacidade do Email

Boa! Nenhum endereço de email está declarado sob a forma de texto!

HTML obsoleto

Fantástico! Não detetámos etiquetas HTML obsoletas.

Dicas de Velocidade

Excelente, este site não usa tablelas dentro de tabelas.
Oh não, o site usa estilos CSS nas etiquetas HTML.
Oh, não! O site utiliza demasiados ficheiros CSS (mais que 4).
Oh, não! O site utiliza demasiados ficheiros JavaScript (mais que 6).
Perfeito, o site tira vantagens da compressão gzip.

Dispositivos Móveis

Otimização para dispositivos móveis

Icon Apple
Meta Viewport Tag
Conteúdo Flash

Otimização

XML Sitemap

Perfeito, o site tem um mapa XML do site (sitemap).

https://www.parexel.com/sitemap.xml

Robots.txt

https://parexel.com/robots.txt

Perfeito, o seu site tem um ficheiro robots.txt.

Analytics

Em falta

Não detetámos nenhuma ferramenta analítica de análise de atividade.

Este tipo de ferramentas (como por exemplo o Google Analytics) permite perceber o comportamento dos visitantes e o tipo de atividade que fazem. No mínimo, uma ferramenta deve estar instalada, sendo que em algumas situações mais do que uma pode ser útil.

PageSpeed Insights

Dispositivo
Categorias

Free SEO Testing Tool

Free SEO Testing Tool é uma ferramenta gratuita que o ajuda a avaliar o seu site